7Neurologic Systemic Causes

FTinnitus as a neurologic symptom

Most tinnitus begins in the cochlea and is then sustained by the brain. A smaller but important group begins in the nervous system itself — in the white-matter tracts, the brainstem auditory nuclei, or the pressure environment that surrounds them. The clinical task is to notice when tinnitus is travelling in neurologic company rather than alone.

The tell-tale clues are rarely in the sound. They are in the context: a younger patient, fluctuation that tracks relapses, accompanying vertigo, diplopia, dysarthria or limb symptoms, headache with a postural or pulsatile character, or visual obscurations. When these appear, the differential widens from the ear to the whole neuraxis [2013].

This module walks through the conditions in which a neurologic context reframes tinnitus: multiple sclerosis, migraine and vestibular migraine, idiopathic intracranial hypertension, Chiari malformation, and the quieter associations with neurodegeneration.

TMultiple sclerosis and the demyelinated auditory pathway

Tinnitus is not a classic feature of multiple sclerosis, yet it can be the presenting symptom when a demyelinating plaque lands on the central auditory pathway — the cochlear nucleus, the lateral lemniscus, the inferior colliculus or the brainstem connections. A plaque here produces a partial deafferentation, and the central response to that loss is perceived as phantom sound.

Acute tinnitus with hearing loss has been documented as the first manifestation of MS, including in children, which is why unexplained sudden auditory symptoms in a young patient with any other neurologic sign deserve MRI rather than reassurance [2005]. MS-related tinnitus tends to be unilateral, may fluctuate with disease activity, and often travels with vertigo, diplopia or dysarthria during a brainstem relapse.

Brainstem auditory evoked responses may show prolonged latencies that betray central conduction delay even when the audiogram looks reassuring. Treatment is the treatment of the relapse: corticosteroids during active demyelination and disease-modifying therapy to limit recurrence, rather than ear-directed therapy.

TMigraine and vestibular migraine

Migraine is a brain-wide disorder of sensory gain, and the auditory system is not exempt. Phonophobia is built into the diagnostic criteria, and many migraineurs report tinnitus and aural fullness that wax and wane with their headache cycle. The shared currency is cortical and brainstem hyperexcitability rather than cochlear damage.

Vestibular migraine is the entity to recognise, because it is common, treatable and frequently mistaken for an ear disease. The Barany Society and International Headache Society criteria require recurrent vestibular symptoms of moderate severity, a history of migraine, and migrainous features during at least half of the episodes [2022]. Tinnitus and transient hearing change can accompany the attacks, which is exactly why vestibular migraine is so often confused with Meniere disease.

The reframing matters: when tinnitus belongs to a migraine biography, management shifts toward trigger control, lifestyle measures and migraine prophylaxis rather than diuretics or intratympanic injections.

CIdiopathic intracranial hypertension

Idiopathic intracranial hypertension (IIH) raises cerebrospinal fluid pressure without a mass or hydrocephalus, classically in a young woman with a raised body-mass index. Its signature auditory symptom is pulsatile tinnitus — a rhythmic whooshing synchronous with the heartbeat — thought to arise from transmission of arterial pulsation across compressed or stenotic dural venous sinuses.

The accompanying story is the diagnostic key: headache that is worse on lying flat or on waking, transient visual obscurations, and papilloedema on fundoscopy. Pulsatile tinnitus can be a remarkably persistent symptom; in IIH cohorts a substantial fraction of patients still report it after treatment, and the number of associated radiologic abnormalities (such as venous sinus stenosis) tracks with the likelihood of pulsatile tinnitus [2025].

Recognising IIH is urgent because untreated papilloedema threatens vision. Weight management, acetazolamide and, in selected cases, venous sinus stenting or shunting address the pressure — and the tinnitus — at source [2025].

CChiari malformation and neurodegeneration

Chiari type I malformation — herniation of the cerebellar tonsils through the foramen magnum — can produce tinnitus by compressing the brainstem and vestibulocochlear nerve at the cerebellopontine angle, or by disturbing cerebrospinal fluid pulsation. The tinnitus is often pulsatile or positional and travels with cough-or-Valsalva headache, ataxia, dysphagia or sensory symptoms. MRI of the brain and cervical spine is diagnostic, and posterior-fossa decompression can relieve symptoms when CSF flow is restored.

At the far end of the neurologic spectrum, large population studies have linked persistent tinnitus to a modestly increased risk of cognitive decline and neurodegenerative disease. The relationship is associative rather than causal: shared vascular risk, the cognitive load of chronic auditory attention, and overlapping limbic-network dysfunction are all plausible threads. The practical message is not alarm but vigilance — treat the hearing loss, treat the distress, and keep the brain engaged.